James N. Wilson, Director at CORCEPT THERAPEUTICS INC (CORT), sold 15,000 shares at $3.01 ($45K) on 2011-09-07, disclosed to the SEC on 2011-09-07.
Scheduled sale ($45k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.00 | 10,000 | $30K | 66.6% |
| 2 | $3.01 | 5,000 | $15K | 33.4% |
| Total | $3.00 avg | 15,000 | $45K | 100% |
| Filing → |
| CORT | SELL | 2026-07-17 | $883K | — | Filing → |
| CORT | SELL | 2026-06-18 | $832K | — | Filing → |
| CORT | SELL | 2016-11-14 | $1.4M | — | Filing → |